SSII on Nasdaq
SS Innovations International, Inc.
SS Innovations International, Inc. is an American surgical and medical instruments and apparatus company.2 It is headquartered in Fort Lauderdale, United States.2 Its shares trade on Nasdaq under the symbol SSII.2
$2.65 down 0.06 (2.04%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 21, 2026.
Overview
Compare with KORU Medical Systems, Inc., Brainsway Ltd. or SANUWAVE Health, Inc., or pick any stock.
- TickerSSII on Nasdaq2
- IndustrySurgical & Medical Instruments & Apparatus2
- HeadquartersFort Lauderdale, United States2
- Incorporated inFL4
- Business address405, 3Rd Floor, Ilabs Info Tech Centre, Udyog Vihar, Phase Iii, Gurugram, 1220164
- Filer categoryNon-accelerated filer, Smaller reporting company4
- Legal formCorporation2
- LEI549300R1NOCJPRJEMP712
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O COHEN, BARRY F, 33316 Fort Lauderdale, United States2
- Registered withFlorida Division of Corporations, P150000117222
See how the biggest companies compare on our leaderboards
Floor, iLabs Info Technology Centre, Udyog Vihar, Phase III, Gurugram, Haryana 122016, India. Our telephone number is +91 73375 53469.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
System Sales brought in 90% of the revenue SS Innovations International, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| System Sales | $19.5M | $38.4M |
| Instruments Sale | $942.5K | $3.2M |
| Warranty Sale | $177.5K | $877.0K |
| Lease Income | $71.7K | $70.9K |
Regions
India brought in 87% of the revenue SS Innovations International, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| India | $19.1M | $36.8M |
| PH | $2.2M | |
| ID | $595.9K | $1.0M |
| South America | $468.2K | $1.0M |
| IQ | $766.3K | |
| CY | $522.3K | |
| OM | $85.4K | |
| AE | $31.3K | |
| NP | $501.7K | $18.7K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue50¢$22.9M
- Research and development8¢$3.7M
- Selling, general and admin33¢$14.8M
- Income tax9¢$4.0M
Out of $42.5M in revenue.6 The company lost money this year.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.4M7 | $5.9M7 | $20.6M6 | $42.5M6 | |||
| Cost of revenue | $1.4M7 | $5.1M8 | $12.2M6 | $22.9M6 | |||
| Gross profit | $60.6K7 | $725.5K8 | $8.5M6 | $19.5M6 | |||
| Research and development | $60.9K9 | $3.0K10 | $1.0K11 | $987.4K7 | $1.1M8 | $2.5M6 | $3.7M6 |
| Selling, general and admin | $1.9M7 | $10.1M8 | $10.2M6 | $14.8M6 | |||
| Operating expenses | $1.4M11 | $3.0M7 | $21.0M8 | $27.4M6 | $27.7M6 | ||
| Operating income | -$3.0M7 | -$20.3M8 | -$19.0M6 | -$8.2M6 | |||
| Interest | $19.7K9 | $1.1K10 | $162.0K14 | $523.4K14 | |||
| Income before tax | -$1.5M11 | -$3.2M7 | -$20.9M8 | -$19.2M6 | -$8.2M6 | ||
| Income tax | $4.0M6 | ||||||
| Net income | -$3.4M9 | -$1.1M10 | -$1.5M11 | -$3.2M7 | -$20.9M8 | -$19.2M6 | -$12.1M6 |
| Earnings per share | -$0.169 | -$0.0510 | -$0.0511 | -$0.037 | -$0.148 | -$0.116 | -$0.066 |
| Earnings per share (diluted) | -$0.169 | -$0.0510 | -$0.0511 | -$0.037 | -$0.148 | -$0.116 | -$0.066 |
| Shares (weighted, basic) | 28.5M shares11 | 128.2M shares7 | 144.9M shares8 | 170.8M shares6 | 190.0M shares6 | ||
| Shares (weighted, diluted) | 28.5M shares11 | 128.2M shares7 | 152.1M shares8 | 181.2M shares6 | 198.7M shares6 |
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash | $28.5K15 | $160.7K10 | $405.8K10 | $217.2K7 | $2.0M8 | $466.5K6 | $3.2M6 |
| Receivables | $156.9K7 | $1.9M8 | $4.5M6 | $12.4M6 | |||
| Inventory | $904.1K7 | $7.0M8 | $10.2M6 | $17.1M6 | |||
| Current assets | $34.8K9 | $163.0K10 | $408.1K11 | $4.1M7 | $21.4M8 | $27.4M6 | $48.8M6 |
| Property, plant and equipment | $20.5K11 | $417.0K7 | $706.4K8 | $5.4M6 | $9.1M6 | ||
| Total assets | $132.5K9 | $317.9K10 | $428.6K11 | $7.0M7 | $31.5M8 | $42.4M6 | $74.2M6 |
| Accounts payable | $124.6K11 | $165.5K7 | $901.6K8 | $2.3M6 | $5.1M6 | ||
| Short-term debt | $120.9K7 | $510.2K8 | |||||
| Current liabilities | $1.2M9 | $1.2M10 | $287.3K11 | $7.8M7 | $8.5M8 | $21.3M6 | $26.2M6 |
| Long-term debt | $469.0K7 | $510.2K7 | |||||
| Long-term liabilities | $1.9M7 | $3.3M8 | $7.6M8 | ||||
| Total liabilities | $9.7M7 | $11.8M8 | $28.9M6 | $36.0M6 | |||
| Retained earnings | -$8.5M11 | -$3.6M7 | -$24.5M8 | -$43.7M6 | -$55.8M6 | ||
| Shareholders’ equity | -$1.1M9 | -$869.0K11 | $585.6K7 | -$2.7M8 | $19.7M6 | $13.5M6 | $38.2M6 |
| Shares outstanding | 21.9M shares9 | 25.7M shares10 | 37.8M shares11 | 128.2M shares7 | 170.7M shares8 | 171.6M shares6 | 194.2M shares6 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$424.1K9 | -$90.5K10 | -$363.0K11 | -$6.0M7 | -$15.4M8 | -$9.5M6 | -$18.5M6 |
| Depreciation and amortization | $18.8K11 | $96.6K7 | $152.7K8 | $436.0K6 | $1.1M6 | ||
| Stock-based compensation | $767.2K11 | $865.5K14 | $9.7M8 | $14.3M6 | $8.1M6 | ||
| Capital spending | $220.3K14 | $453.3K8 | $661.5K6 | $3.7M6 | |||
| Free cash flow | -$6.2M | -$15.8M | -$10.2M | -$22.2M | |||
| Cash from investing | $38.1K11 | $240.8K7 | -$453.3K8 | -$661.5K6 | -$3.7M6 | ||
| Share buybacks | $26.0K10 | ||||||
| Cash from financing | $569.9K11 | $5.9M7 | $22.8M8 | $9.4M6 | $26.2M6 |
Compare SS Innovations International, Inc. with another company
Corporate structure
SS Innovations International, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of SS Innovations International, Inc.
- Sudhir Srivastava Filed SCHEDULE 13G/A on SS Innovations International, Inc., latest May 4, 2026 (4 filings since Feb 9, 2024)
- Frederic H. Moll Filed SCHEDULE 13G/A on SS Innovations International, Inc., latest May 15, 2025 (3 filings since Feb 14, 2024)
- Barry F. Cohen Filed SCHEDULE 13G on SS Innovations International, Inc., latest Feb 13, 2025
- Ranjan R. Pai Filed SCHEDULE 13G/A on SS Innovations International, Inc., latest Feb 12, 2025 (2 filings since Dec 2, 2024)
- SS Innovations International, Inc. Fort Lauderdale, Florida, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What SS Innovations International, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Accumulated depreciation | $1.5M6 Dec 31, 2025 | $645.5K6 Dec 31, 2024 | +139.5% |
| Property and equipment, net | $9.1M6 Dec 31, 2025 | $5.4M6 Dec 31, 2024 | +69.0% |
| Operating-lease assets (leased space) | $2.8M6 Dec 31, 2025 | $2.6M6 Dec 31, 2024 | +5.0% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $3.2M6 Dec 31, 2025 | $466.5K6 Dec 31, 2024 | +587.3% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $17.1M6 Dec 31, 2025 | $10.2M6 Dec 31, 2024 | +67.2% |
| Raw materials | $502.4K6 Dec 31, 2025 | $970.0K6 Dec 31, 2024 | −48.2% |
| Work in process | $1.4M6 Dec 31, 2025 | $1.4M6 Dec 31, 2024 | −0.6% |
| Finished goods | $8.7M6 Dec 31, 2025 | $4.3M6 Dec 31, 2024 | +102.3% |
Properties, in its own words
We lease approximately 75,000 square feet in Gurugram, Delhi NCR, India, which serves as our headquarters as well as our manufacturing facility. The facility, spread over three floors, is leased pursuant to a nine-year lease expiring in March 2030 for the third floor, another nine-year lease expiring in May 2032 for the ground floor, another six-year lease expiring in July 2030 for the first floor and a five-year lease expiring in March 2030 for Basement 3. All the leases are further renewable under similar mutually agreed terms.
Item 2 of the 10-K filed Mar 10, 2026.5
Leadership
Who has led SS Innovations International, Inc., and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
Chief operating officer
- Chief executive officerPascual Srivastava Vishwajyoti Feb 20, 2026 to now16
- Chief executive officerSudhir Srivastava Nov 9, 2023 to Feb 20, 202617
- ChairSudhir Srivastava Nov 9, 2023 to now17
- PresidentPascual Srivastava Vishwajyoti Nov 9, 2023 to Nov 29, 202318
- Chief financial officerMilan Rao Jan 30, 2026 to Aug 4, 202619
- Chief financial officerSarah Romano Aug 4, 2026 to now20
- Chief financial officerArvind Palaniappan Palaniappan May 19, 2025 to Oct 3, 202521
- Chief financial officerNaveen Kumar Amar Oct 3, 2025 to Jan 30, 202622
- Chief financial officerKumar Sethi Anup Nov 9, 2023 to May 19, 202523
- Chief operating officerMilan Rao Jan 30, 2026 to now19
Board members and other officers (5)
- Board memberFrederic H. Moll Aug 22, 2024 to now24
- Board memberTimothy P. Adams Aug 23, 2024 to now25
- Board memberAnnadurai Mylswamy Nov 9, 2023 to Nov 9, 202326
- Board memberSampige Prasannakumar Somashekar Nov 9, 2023 to now27
- Board memberPascual Srivastava Vishwajyoti Nov 29, 2023 to now28
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Chief Operating Officer - Americas and DirectorBarry F. Cohen named Feb 27, 2024 to Mar 19, 202629
- Chief Executive Officer - Asia Pacific and DirectorVishwajyoti P. Srivastava named Feb 27, 2024 to Mar 19, 202629
- Executive OfficerAnup Kumar Sethi named Feb 27, 202430
- DirectorMylswamy F. Annadurai named Feb 27, 2024 to Mar 19, 202629
- DirectorS.P. F. Somashekhar named Feb 27, 2024 to Mar 19, 202629
Former names
- AVRA Medical Robotics, Inc.Jun 3, 2016 to Apr 14, 20234
Timeline
- Oct 13, 20268-K Entered a material agreement; New debt or obligation31
- Oct 13, 20268-K Other events32
- Oct 5, 20268-K Regulation FD disclosure33
- Sep 10, 20268-K Other events34
- Aug 26, 20268-K Executive or director change35
- Aug 13, 20268-K Results of operations; Regulation FD disclosure36
- Jul 17, 20268-K Other events37
- Jul 14, 20268-K Executive or director change38
- Jul 7, 20268-K Other events39
- Jun 30, 20268-K Other events40
- Jun 18, 20268-K Entered a material agreement41
- Jun 15, 20268-K Regulation FD disclosure42
- Feb 20, 2026New chief executive Pascual Srivastava Vishwajyoti becomes CEO16
- Nov 9, 2023New chief executive Sudhir Srivastava becomes CEO17
- Feb 4, 2015Founded SS Innovations International, Inc. is founded2
Calendar
Coming up
- Oct 27, 2026Reports results for the quarter ending Sep/202643
When it reported results
- Aug 13, 2026Reported quarterly or annual results36
- May 13, 2026Reported quarterly or annual results44
- Mar 10, 2026Reported quarterly or annual results45
- Jan 13, 2026Reported quarterly or annual results46
- Oct 28, 2025Reported quarterly or annual results47
- Aug 7, 2025Reported quarterly or annual results48
- May 14, 2025Reported quarterly or annual results49
- Mar 31, 2025Reported quarterly or annual results50
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
263 filings to the SEC since October 2021: 10 annual reports, 25 quarterly reports, 104 major events, 93 insider forms, 10 large holders, 2 private raises, 19 other. The latest 20:
- Oct 13, 20268-K CURRENT REPORT EDGAR
- Oct 13, 20268-K CURRENT REPORT EDGAR
- Oct 9, 20264 EDGAR
- Oct 9, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
- Oct 5, 20268-K CURRENT REPORT EDGAR
- Sep 10, 20268-K CURRENT REPORT EDGAR
- Sep 9, 20264 EDGAR
- Aug 26, 20268-K CURRENT REPORT EDGAR
- Aug 14, 20264 EDGAR
- Aug 13, 20268-K CURRENT REPORT EDGAR
- Aug 13, 202610-Q QUARTERLY REPORT EDGAR
- Aug 4, 20263 EDGAR
- Jul 17, 20268-K CURRENT REPORT EDGAR
- Jul 14, 20268-K CURRENT REPORT EDGAR
- Jul 7, 20268-K CURRENT REPORT EDGAR
- Jun 30, 20268-K CURRENT REPORT EDGAR
- Jun 18, 20268-K CURRENT REPORT EDGAR
- Jun 18, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
- Jun 15, 20268-K CURRENT REPORT EDGAR
- Jun 8, 2026S-8 REGISTRATION STATEMENT EDGAR
The 263 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
58 open-market trades by officers, directors and large owners since October 2021: 46 buys and 12 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Sudhir SrivastavaChairman and CEO | Sale | 33,333 | $3.00 | $100.0K | Form 4 |
| Mar 6, 2026 | MOLL FREDERIC HDirector | Buy | 501,253 | $3.99 | $2.0M | Form 4 |
| Mar 6, 2026 | Adams Timothy P.Director | Buy | 300,000 | $3.99 | $1.2M | Form 4 |
| Mar 6, 2026 | Sudhir SrivastavaChairman and CEO | Buy | 498,753 | $4.01 | $2.0M | Form 4 |
| Apr 22, 2025 | Cohen Barry FCOO - Americas | Buy | 326 | $8.97 | $2.9K | Form 4 |
| Apr 22, 2025 | Cohen Barry FCOO - Americas | Buy | 326 | $8.97 | $2.9K | Form 4 |
| Apr 17, 2025 | Cohen Barry FCOO - Americas | Buy | 100 | $8.75 | $875 | Form 4 |
| Apr 17, 2025 | Cohen Barry FCOO - Americas | Buy | 100 | $8.75 | $875 | Form 4 |
| Apr 16, 2025 | Cohen Barry FCOO - Americas | Buy | 107 | $9.50 | $1.0K | Form 4 |
| Apr 14, 2025 | Cohen Barry FCOO - Americas | Buy | 103 | $8.93 | $920 | Form 4 |
| Apr 10, 2025 | Cohen Barry FCOO - Americas | Buy | 200 | $8.93 | $1.8K | Form 4 |
| Apr 9, 2025 | Cohen Barry FCOO - Americas | Buy | 300 | $8.47 | $2.5K | Form 4 |
| Apr 8, 2025 | Cohen Barry FCOO - Americas | Buy | 500 | $9.16 | $4.6K | Form 4 |
| Apr 2, 2025 | Cohen Barry FCOO - Americas | Buy | 420 | $9.20 | $3.9K | Form 4 |
| Apr 1, 2025 | Cohen Barry FCOO - Americas | Buy | 2,570 | $9.72 | $25.0K | Form 4 |
| Mar 31, 2025 | Cohen Barry FCOO - Americas | Buy | 100 | $10.00 | $1.0K | Form 4 |
| Feb 20, 2025 | MOLL FREDERIC HDirector | Buy | 3,645,224 | $1.37 | $5.0M | Form 4 |
| Feb 20, 2025 | SRIVASTAVA SUDHIRChairman and CEO | Sale | 3,645,224 | $1.37 | $5.0M | Form 4 |
| Feb 14, 2025 | Adams Timothy P.Director | Buy | 1,250,000 | $1.37 | $1.7M | Form 4 |
| Feb 14, 2025 | SRIVASTAVA SUDHIRChairman and CEO | Sale | 1,250,000 | $1.37 | $1.7M | Form 4 |
All 58 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Sudhir SrivastavaSCHEDULE 13G/A, 4 filings Feb 9, 2024 to May 4, 202651
- Frederic H. MollSCHEDULE 13G/A, 3 filings Feb 14, 2024 to May 15, 202552
- Barry F. CohenSCHEDULE 13G, 1 filing Feb 13, 202553
- Ranjan R. PaiSCHEDULE 13G/A, 2 filings Dec 2, 2024 to Feb 12, 202554
Money raised
Private offerings the company reported to the SEC on Form D.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Hood River Capital Management LLC | 833,333 | $3.5M | 0.0% | No change |
| Inspire Investing, LLC | 186,297 | $773.1K | 0.0% | +81,673 |
| Eversept Partners, LP | 110,157 | $457.2K | 0.0% | No change |
| JNBA Financial Advisors | 102,291 | $424.5K | 0.0% | −14,646 |
| UBS Group AG | 51,208 | $212.5K | 0.0% | −104,333 |
| AlphaCentric Advisors LLC | 50,000 | $207.5K | 0.2% | No change |
| Geode Capital Management, LLC | 41,771 | $173.3K | 0.0% | +5,495 |
| Forum Financial Management, LP | 38,469 | $159.6K | 0.0% | No change |
| AlTi Global, Inc. | 20,555 | $85.3K | 0.0% | No change |
| Mariner, LLC | 19,211 | $79.7K | 0.0% | +554 |
| IFC & Insurance Marketing, Inc. | 18,655 | $77.4K | 0.1% | +1,925 |
| Y-Intercept (Hong Kong) Ltd | 17,934 | $74.4K | 0.0% | New |
| State Street Corp | 14,522 | $60.3K | 0.0% | −1,064 |
| PNC Financial Services Group, Inc. | 13,627 | $56.6K | 0.0% | No change |
| Morgan Stanley | 3,000 | $12.4K | 0.0% | No change |
| Steward Partners Investment Advisory, LLC | 1,100 | $4.6K | 0.0% | No change |
| NFSG Corp | 916 | $3.8K | 0.0% | −400 |
| Jones Financial Companies Lllp | 376 | $1.3K | 0.0% | No change |
| Basecamp Wealth Advisors LLC | 300 | $1.2K | 0.0% | No change |
| Handelsbanken Fonder AB | 120,000 | $498 | 0.0% | No change |
| Osaic Holdings, Inc. | 10 | $41 | 0.0% | No change |
| Royal Bank Of Canada | 85 | $0 | 0.0% | −165 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How SS Innovations International, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSS Innovations International, Inc.1
- CIK0001676163
- Employer ID (EIN)47-34788545
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inFlorida5
- Fiscal year endsDecember 311
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address405, 3Rd Floor, Ilabs Info Tech Centre, Udyog Vihar, Phase Iii, Gurugram, Haryana 122016, India1
- Phone(954) 478-14101
- Shares outstanding200,385,435 as of Aug 12, 202613
- Public float$270.1M as of Jun 30, 20255
- AuditorBDO India Services Private Limited, Gurugram, India PCAOB ID 6074; no auditor attestation of internal control over financial reporting5
- On EDGAR sinceJun 3, 20161
- Filings308 in all: 8-K (113), 4 (76), 10-Q (28), 3 (12), 10-K (9), 10-Q/A (6), CORRESP (6), SCHEDULE 13G/A (6)1
All 31 form types
UPLOAD (6), 10-K/A (4), D (4), S-1 (4), 4/A (3), 424B5 (3), EFFECT (3), NT 10-K (3), S-1/A (3), SC 13G (3), 3/A (2), RW (2), S-8 (2), 8-A12B (1), 8-A12G (1), 8-K/A (1), CERT (1), DRS (1), NT 10-Q (1), POS AM (1), S-3 (1), SCHEDULE 13G (1), SEC STAFF ACTION (1)
- Latest filingsAnnual report (10-K) Mar 10, 2026
Quarterly report (10-Q) Aug 13, 2026
Latest 8-K (8-K) Oct 13, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.0001 per share | SSII | Nasdaq |
From the cover page of the 10-K filed Mar 10, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
Legal proceedings
On May 26, 2020, Quinn Emmanuel filed a petition in the Supreme Court of the State of New York, New York County against Avra Surgical, the Company (then known as Avra Medical Robotics, Inc.), Barry F. Cohen, Jared B. Stamell, an attorney affiliated with Avra Surgical, and various individuals who at that time were or had been affiliated with Avra Surgical and or us (collectively, “Respondents”). The petition sought to recover the legal fees from the Respondents on the basis that they were “alter egos” of Avra Surgical.
As we and Mr. Cohen never received notice of the filing of the petition or of subsequent proceedings (although Quinn Emmanuel filed affidavits with the court stating that they had been duly served), neither we nor Mr. Cohen entered an appearance in the matter.
In early 2024, we learned from a third party that in November 2020, the court had rendered a decision holding that we and Messrs. Cohen and Stamell were “alter egos” of Avra Surgical and therefore were liable for payment of the Quinn Emmanuel legal fees. In addition, we also learned that in December 2023, the court ordered the entry of a judgment against Avra Surgical, us and Messrs. Cohen and Stamell in the amount of $296,000 plus interest from November 2020.
In 2023, Mr. Stamell appealed the judgement against him on the basis that Quinn Emmanuel had not presented any evidence to support the finding that Mr. Stamell was an alter ego of Avra Surgical or that Avra Surgical had transferred any assets to us. The Appellate Division, First Department ruled in favor of Mr. Stamell and in December 2024 entered an order vacating the judgment against him.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3Yahoo FinanceSSII quote
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19SEC EDGARMilan Rao, Chief financial officer
- 20
- 21
- 22
- 23
- 24SEC EDGARFrederic H. Moll, Board member
- 25SEC EDGARTimothy P. Adams, Board member
- 26SEC EDGARAnnadurai Mylswamy, Board member
- 27
- 28
- 29
- 30
- 31
- 32SEC EDGAROther events
- 33SEC EDGARRegulation FD disclosure
- 34SEC EDGAROther events
- 35SEC EDGARExecutive or director change
- 36
- 37SEC EDGAROther events
- 38SEC EDGARExecutive or director change
- 39SEC EDGAROther events
- 40SEC EDGAROther events
- 41SEC EDGAREntered a material agreement
- 42SEC EDGARRegulation FD disclosure
- 43NasdaqNasdaq calendar
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54